Skip to main content
Year archive

SYNTARA LIMITED — 2021 filings

All 96 regulatory filings released by SYNTARA LIMITED (SNT) in 2021, sourced directly from the official regulator.

96 Filings
2021 Period
2021 filings (96)
Filing Released Lang
Change of Director's Interest Notice 2 pages 149.8KB
Director's Dealing
2021-12-23 English
Change of Director's Interest Notice 3 pages 147.7KB
Director's Dealing
2021-12-22 English
Change of Director's Interest Notice 2 pages 145.5KB
Director's Dealing
2021-12-22 English
Change of Director's Interest Notice 3 pages 148.1KB
Director's Dealing
2021-12-21 English
Change of Director's Interest Notice 2 pages 149.4KB
Director's Dealing
2021-12-21 English
Application for quotation of securities - PXS 6 pages 28.3KB
Share Issue/Capital Change
2021-12-21 English
Application for quotation of securities - PXS 5 pages 25.9KB
Share Issue/Capital Change
2021-12-20 English
Share Purchase Plan 2 pages 145.1KB
Capital/Financing Update
2021-12-19 English
Investor presentation 23 pages 2.1MB
Investor Presentation
2021-12-07 English
Investor Briefing 2 pages 108.2KB
Investor Presentation
2021-12-01 English
Application for quotation of securities - PXS 6 pages 27.8KB
Share Issue/Capital Change
2021-11-29 English
Security Purchase Plan 22 pages 401.3KB
Capital/Financing Update
2021-11-24 English
Application for quotation of securities - PXS 6 pages 27.5KB
Share Issue/Capital Change
2021-11-23 English
Section 708A(5)(e) Notice 1 page 145.2KB
Capital/Financing Update
2021-11-23 English
Application for quotation of securities - PXS 5 pages 26.2KB
Share Issue/Capital Change
2021-11-22 English
Proposed issue of securities - PXS 7 pages 30.9KB
Capital/Financing Update
2021-11-17 English
Placement 3 pages 152.4KB
Capital/Financing Update
2021-11-16 English
Proposed issue of securities - PXS 5 pages 27.5KB
Capital/Financing Update
2021-11-16 English
Investor Presentation 29 pages 2.2MB
Investor Presentation
2021-11-16 English
Trading Halt 2 pages 228.8KB
Capital/Financing Update
2021-11-14 English
FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study 3 pages 117.7KB
Regulatory Filings
2021-11-08 English
Notification regarding unquoted securities - PXS 7 pages 29.5KB
Capital/Financing Update
2021-11-04 English
Investor Presentation 20 pages 2.0MB
Investor Presentation
2021-11-03 English
Chairman's Address to Shareholders 2 pages 165.7KB
AGM Information
2021-11-02 English
CEO Presentation to 2021 AGM 12 pages 1.4MB
AGM Information
2021-11-02 English
Results of Meeting 2 pages 284.9KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-02 English
Constitution as amended 3 November 49 pages 356.3KB
Governance Information
2021-11-02 English
Notification regarding unquoted securities - PXS 6 pages 28.2KB
Share Issue/Capital Change
2021-11-02 English
Change of Director's Interest Notice 2 pages 144.0KB
Director's Dealing
2021-11-02 English
Appendix 4C Cash Flow Report 4 pages 199.5KB
Interim / Quarterly Report
2021-10-27 English
Quarterly Activities Report 12 pages 517.4KB
Interim / Quarterly Report
2021-10-27 English
Investor Presentation - September Quarterly Update 9 pages 1.2MB
Investor Presentation
2021-10-27 English
Pharmaxis Quarterly Shareholder Update and Investor Briefing 2 pages 128.6KB
Investor Presentation
2021-10-24 English
PXS Doses First Patient in Phase 2 Bone Marrow Cancer Trial 2 pages 119.2KB
Regulatory Filings
2021-10-12 English
PXS Cleared to Progress to Phase 2 Bone Marrow Cancer Trial 4 pages 165.5KB
Regulatory Filings
2021-10-04 English
Annual Report to shareholders 68 pages 875.4KB
Annual Report
2021-09-30 English
Notice of Annual General Meeting/Proxy Form 22 pages 486.2KB
Regulatory Filings
2021-09-30 English
Appendix 4G 14 pages 190.5KB
Regulatory Filings
2021-09-30 English
Corporate Governance Statement 15 pages 243.4KB
Governance Information
2021-09-30 English
Change in substantial holding 7 pages 436.5KB
Major Shareholding Notification
2021-09-26 English
Pharmaxis to Present at Biotech Webinar 1 page 98.4
Investor Presentation
2021-09-21 English
Application for quotation of securities - PXS 9 pages 35.0KB
Capital/Financing Update
2021-09-20 English
Application for quotation of securities - PXS 6 pages 27.8KB
Share Issue/Capital Change
2021-09-19 English
Notification of cessation of securities - PXS 4 pages 24.3KB
Regulatory Filings
2021-09-19 English
Application for quotation of securities - PXS 6 pages 27.8KB
Share Issue/Capital Change
2021-09-08 English
Investor Presentation 19 pages 1.6MB
Investor Presentation
2021-09-06 English
Pharmaxis Treatment to Prevent Wound and Burns Scars Clears 2 pages 132.5KB
Regulatory Filings
2021-08-30 English
Application for quotation of securities - PXS 7 pages 30.9KB
Share Issue/Capital Change
2021-08-25 English
Application for quotation of securities - PXS 6 pages 27.8KB
Capital/Financing Update
2021-08-19 English
PXS Grants Exclusive Option to Develop High Payload Inhaler 3 pages 169.4KB
Capital/Financing Update
2021-08-16 English
Notification of cessation of securities - PXS 4 pages 24.3KB
Regulatory Filings
2021-08-12 English
Change of Director's Interest Notice 2 pages 149.1KB
Director's Dealing
2021-08-12 English
Proposed Issue of Employee Options 2 pages 167.5KB
Share Issue/Capital Change
2021-08-12 English
Notification regarding unquoted securities - PXS 7 pages 30.4KB
Share Issue/Capital Change
2021-08-12 English
Preliminary Final Report 64 pages 967.2KB
Annual Report
2021-08-11 English
PXS Drug Decreases Tumour Burden in Liver Cancer Model 3 pages 136.5KB
Regulatory Filings
2021-08-04 English
PXS Commences Final Cohort Dosing in Phase 1c Cancer Trial 3 pages 117.0KB
Regulatory Filings
2021-08-03 English
Investor Presentation Quarterly Shareholder Update 7 pages 1.0MB
Investor Presentation
2021-07-28 English
Quarterly Activities/Appendix 4C Cash Flow Report 5 pages 185.9KB
Interim / Quarterly Report
2021-07-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.1MB
Interim / Quarterly Report
2021-07-27 English
Pharmaxis Quarterly Shareholder Investor Briefing 2 pages 128.0KB
Regulatory Filings
2021-07-26 English
Pharmaxis Shareholder Investor Call - Corrected Link 2 pages 127.6KB
Investor Presentation
2021-07-26 English
Application for quotation of securities - PXS 6 pages 27.9KB
Share Issue/Capital Change
2021-07-06 English
Application for quotation of securities - PXS 6 pages 27.9KB
Capital/Financing Update
2021-07-06 English
PXS Sells Australian Distribution Rights for A$2m 2 pages 146.0KB
Capital/Financing Update
2021-06-30 English
Application for quotation of securities - PXS 6 pages 27.8KB
Share Issue/Capital Change
2021-06-29 English
Notification of cessation of securities - PXS 4 pages 24.3KB
Share Issue/Capital Change
2021-06-29 English
Change of Director's Interest Notice 3 pages 159.8KB
Director's Dealing
2021-06-28 English
PXS Announces First Results in Bone Marrow Cancer Trial 3 pages 117.6KB
Capital/Financing Update
2021-06-28 English
Change in substantial holding 4 pages 160.4KB
Major Shareholding Notification
2021-06-28 English
Progression of Clinical Trial in Bone Marrow Cancer 3 pages 116.3KB
Regulatory Filings
2021-06-09 English
Investor Presentation - 4 June 2021 32 pages 2.5MB
Investor Presentation
2021-06-03 English
Pharmaxis Investor Briefing 2 pages 140.2KB
Investor Presentation
2021-05-30 English
Change of Director's Interest Notice 3 pages 150.3KB
Director's Dealing
2021-05-03 English
Promising New Drug to Tackle Brain Cancer 3 pages 137.3KB
Regulatory Filings
2021-05-02 English
Appendix 4C - quarterly 5 pages 185.8KB
Interim / Quarterly Report
2021-04-29 English
Quarterly Activity Report 10 pages 495.8KB
Interim / Quarterly Report
2021-04-29 English
Appendix 2A - Exercise of Employee Options 15 pages 198.5KB
Regulatory Filings
2021-04-21 English
Section 708A(5)(e) Notice 1 page 145.0KB
Capital/Financing Update
2021-04-20 English
Appendix 2A 15 pages 197.0KB
Regulatory Filings
2021-04-19 English
Becoming a substantial holder 2 pages 122.0KB
Major Shareholding Notification
2021-04-19 English
Placement 3 pages 150.7KB
Capital/Financing Update
2021-04-13 English
Proposed issue of Securities - PXS 5 pages 27.6KB
Capital/Financing Update
2021-04-13 English
Investor Presentation Capital Raising and Growth Outlook 37 pages 2.6MB
Investor Presentation
2021-04-13 English
Sale of Russian Distribution Rights 2 pages 149.1KB
Capital/Financing Update
2021-04-13 English
Trading Halt 2 pages 224.9KB
Capital/Financing Update
2021-04-12 English
Appendix 2A - Exercise of Employee Options 15 pages 198.4KB
Capital/Financing Update
2021-04-06 English
Investor Presentation 30 pages 3.3MB
Investor Presentation
2021-04-06 English
Clinical Trial of Treatment to Prevent Wound and Burns Scars 3 pages 133.1KB
Regulatory Filings
2021-03-30 English
US Commercial Launch of Bronchitol 2 pages 103.2KB
Capital/Financing Update
2021-03-18 English
First Patient Enrolled - Clinical Trial for Cancer Treatment 3 pages 137.0KB
Regulatory Filings
2021-02-21 English
Appendix 2A - Exercise of Employee Options 15 pages 198.4KB
Regulatory Filings
2021-02-14 English
Half Yearly Report and Accounts 23 pages 442.4KB
Interim / Quarterly Report
2021-02-09 English
Pharmaxis Exports CF Drug to US - US$3 Million Milestone 2 pages 105.3KB
Capital/Financing Update
2021-02-08 English
Quarterly Activity Report - December 2020 9 pages 492.7KB
Interim / Quarterly Report
2021-01-28 English
Appendix 4C - quarterly 5 pages 186.5KB
Interim / Quarterly Report
2021-01-28 English